Transplant News and Research RSS Feed - Transplant News and Research

Frailty: A strong risk factor for dying prematurely after kidney transplant

Frailty: A strong risk factor for dying prematurely after kidney transplant

Regardless of age, frailty is a strong risk factor for dying prematurely after a kidney transplant. The finding, which comes from a new study published in the American Journal of Transplantation, suggests that patients should be screened for frailty prior to kidney transplantation, and that those who are identified as frail should be closely monitored after the procedure. [More]
New standard of care for pediatric AML patients who receive umbilical cord transplants

New standard of care for pediatric AML patients who receive umbilical cord transplants

A new standard of care for children facing acute myeloid leukemia (AML) may be clear, following a multi-year study published in the latest edition of the New England Journal of Medicine. [More]
Fewer women than men receive dialysis treatment for chronic kidney disease

Fewer women than men receive dialysis treatment for chronic kidney disease

Women with chronic kidney disease receive dialysis treatment far less often than men. However, women suffer more commonly than men from kidney disease. A publication by the MedUni Vienna and the Arbor Research Collaborative for Health, USA, has highlighted this difference based on international patient data. [More]
Bortezomib drug effective against chronic GVHD

Bortezomib drug effective against chronic GVHD

Researchers at UC Davis have found that the drug bortezomib effectively treats chronic graft-versus-host disease (GVHD), a common and debilitating side effect from allogeneic hematopoietic stem cell transplants. [More]
Novel approach may help detect invasive aspergillosis

Novel approach may help detect invasive aspergillosis

Many different microbes can cause pneumonia, and treatment may be delayed or off target if doctors cannot tell which bug is the culprit. A novel approach—analyzing a patient's breath for key chemical compounds made by the infecting microbe—may help detect invasive aspergillosis, a fungal infection that is a leading cause of mortality in patients with compromised immune systems, according to a proof-of-concept study now online in Clinical Infectious Diseases. [More]
Couple renews multi-million dollar commitment to screen newborn babies for SCID disorders

Couple renews multi-million dollar commitment to screen newborn babies for SCID disorders

Frustrated with the slow pace of implementation of Newborn Screening for Severe Combined Immune Deficiency (SCID), Vicki and Fred Modell renewed a multi-million dollar commitment to screen every baby born in every state for this life threatening condition, often referred to as "Bubble Boy" disease. [More]
CHLA physician discusses urological issues in children

CHLA physician discusses urological issues in children

Children's Hospital Los Angeles physician-scientist Roger E. De Filippo, MD, an associate professor of urology and director of Pediatric Urology Stem Cell Research at the Keck School of Medicine of the University of Southern California discusses how science, technology and parental care can lead to improved pediatric urological health. [More]
Lactobacillus-containing probiotics can improve lupus symptoms

Lactobacillus-containing probiotics can improve lupus symptoms

Lactobacillus species, commonly seen in yogurt cultures, correlate, in the guts of mouse models, with mitigation of lupus symptoms, while Lachnospiraceae, a type of Clostridia, correlate with worsening, according to research published ahead of print in Applied and Environmental Microbiology. [More]
Cell transplantation treatment may benefit people with spinal cord injury

Cell transplantation treatment may benefit people with spinal cord injury

Two studies recently published in Cell Transplantation reveal that cell transplantation may be an effective treatment for spinal cord injury (SCI), a major cause of disability and paralysis with no current restorative therapies. [More]
Noninvasive measure has prognostic value in PAH

Noninvasive measure has prognostic value in PAH

Estimated right atrial pressure, measured using echocardiography, may be a useful prognostic indicator in patients with pulmonary arterial hypertension, a study suggests. [More]
SynCardia Systems wins 2014 New Economy Award for Best Medical Device Company

SynCardia Systems wins 2014 New Economy Award for Best Medical Device Company

SynCardia Systems, Inc., which manufactures the world's only FDA (United States), Health Canada and CE (Europe)-approved Total Artificial Heart, has won the 2014 New Economy Award for Best Medical Device Company. [More]
Improper splinting can lead to swelling and other skin complications

Improper splinting can lead to swelling and other skin complications

More than 90 percent of potential pediatric fractures are splinted improperly in emergency rooms and urgent care centers, which can lead to swelling and skin injuries, according to a study by researchers at the University of Maryland School of Medicine. [More]
Study shows potential of treating recurrent CDI with frozen fecal matter

Study shows potential of treating recurrent CDI with frozen fecal matter

A preliminary study has shown the potential of treating recurrent Clostridium difficile infection (a bacterium that is one of the most common causes of infection of the colon) with oral administration of frozen encapsulated fecal material from unrelated donors, which resulted in an overall rate of resolution of diarrhea of 90 percent, according to a study published in JAMA. [More]
RBX2660 drug candidate highly effective against recurrent Clostridium difficile infection

RBX2660 drug candidate highly effective against recurrent Clostridium difficile infection

Rebiotix Inc. announced today that results of the Phase 2 PUNCH CD Study found that the overall efficacy of RBX2660 in the treatment of recurrent Clostridium difficile infection was 87.1%. The study also found that administration of RBX2660 was well-tolerated and demonstrated satisfactory safety in the 60-day interim analysis. [More]
Neovasc gets conditional IDE approval from FDA to initiate trial for Tiara mitral valve system

Neovasc gets conditional IDE approval from FDA to initiate trial for Tiara mitral valve system

Neovasc Inc. today announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration to initiate the U.S. arm of its TIARA-I Early Feasibility Trial for the Company's Tiara™ transcatheter mitral valve. [More]
Scientists say fundamental theory about how thymus educates immune police appears to be wrong

Scientists say fundamental theory about how thymus educates immune police appears to be wrong

A fundamental theory about how our thymus educates our immune police appears to be wrong, scientists say. [More]
Hospital patients may be at significant risk of infection due to poor hand hygiene

Hospital patients may be at significant risk of infection due to poor hand hygiene

Health technology company Infonaut, a MaRS client, has released a study showing that hospital patients may be at significant risk of infection due to their own poor hand hygiene. [More]
Arizona resident receives donor heart transplant after living with SynCardia Total Artificial Heart

Arizona resident receives donor heart transplant after living with SynCardia Total Artificial Heart

Randy Shepherd, an Arizona resident nicknamed the "tin man," has received a donor heart transplant after 15 months of support from the SynCardia temporary Total Artificial Heart. [More]
MedCure offers Pulsatile Anatomical Trainer service to advance medical research and training

MedCure offers Pulsatile Anatomical Trainer service to advance medical research and training

After three years in development, MedCure, Inc. has perfected a technique that mimics functioning circulatory system processes in cadaveric specimens. [More]
New version of Belmont Rapid Infuser to be introduced at ASA 2014

New version of Belmont Rapid Infuser to be introduced at ASA 2014

Belmont Instrument Corporation, the widely recognized provider of blood and fluid infusers, will be introducing the new version of The Belmont Rapid Infuser, the RI-2 at the American Society of Anesthesiologists Meeting this week in New Orleans, LA. [More]